Search the NLPDP Drug Product Database Drug Information Return to NLPDP Drug Database Search Page Return to Results Page Brand Name: Brand NameThis is the name under which the drug product is marketed. SUMATRIPTAN 50MG TABLET Generic Name: sumatriptan succinate Strength: StrengthThis refers to the amount of the active (medicinal) ingredient (e.g., 50mg, 10 mg/5 mL). 50 mg DIN: DIN A Drug Identification Number (DIN) is an eight digit number assigned by Health Canada to a drug product prior to being marketed in Canada. It uniquely identifies all drug products sold in a dosage form in Canada and is located on the label of prescription and over-the-counter drug products that have been evaluated and authorized for sale in Canada. A DIN uniquely identifies the following product characteristics: manufacturer; product name; active ingredient(s); strength(s) of active ingredient(s); pharmaceutical form; route of administration. 02286521 Dosage Form: Dosage FormThe pharmaceutical dosage form is the form of presentation in which the product is supplied for example (e.g.) tablet, capsule, powder, etc.. TABLET Manufacturer: SANIS HEALTH IN Benefit Status: Benefit Status Open - Drugs which are reimbursed with no criteria or prior approval. Note: a drug may have limitations that restrict usage. Special Authorization - Drugs which are only eligible for reimbursement when a Beneficiary meets specific criteria recommended by the Atlantic Common Drug Review (ACDR), the National Common Drug Review (CDR) or the Joint Oncology Drug Review (JODR) Committees. OPEN Limitations: LimitationsDrugs which are restricted to those individuals who meet the defined restriction requirements. Eg. Limitation based on age such as children under 12 years of age. Coverage limited to 6 doses/30 days Pricing: PricingPricing for the Newfoundland and Labrador Prescription Drug Program is based upon Defined Cost which is the current published manufacturer’s list price for a drug plus 8.5% (unless otherwise specified). Package Size  NLPDP List Price Per Unit 6 3.0228 Interchangeable Drug Products Interchangeable Drug ProductsInterchangeable drug products means pharmaceutical equivalents or pharmaceutical alternatives that are the therapeutic equivalents of and that have the same route of administration as a reference product. The Newfoundland and Labrador Interchangeable Drug Products Formulary (NIDPF) is a list of commonly used drugs which have therapeutic equivalence to a reference product. IMITREX DF 50 MG TABLET TEVA-SUMATRIPTAN DF 50 MG APO-SUMATRIPTAN 50 MG TABLET MYLAN-SUMATRIPTAN 50 MG TABLET PMS-SUMATRIPTAN 50 MG TABLET SUMATRIPTAN DF 50 MG TABLET Interchangeable Unit Price Interchangeable Unit PriceInterchangeable Unit Price – the lowest unit price of all drug products within an NIDPF category. 3.0228 ATC ATCThe Anatomical Therapeutic Chemical (ATC) is a classification system, where the active substances are divided into different groups according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties. N02CC01 - SUMATRIPTAN Return to NLPDP Drug Database Search Page